Metformin attenuates autoimmune disease of the neuromotor system in animal models of myasthenia gravis.

In conclusion, the above results indicate that metformin may have therapeutic value for the clinical treatment of MG.
PMID: 31437793 [PubMed - as supplied by publisher]

Source: International Immunopharmacology - August 18, 2019 Category: Allergy & Immunology Authors: Cui Y, Chang L, Wang C, Han X, Mu L, Hao Y, Liu C, Zhao J, Zhang T, Zhang H, Zhang Y, Liu Y, Zhao W, Wang J, Liu X, Sun B, Wang G, Kong Q, Han J, Li H Tags: Int Immunopharmacol Source Type: research